Millennium Management
PLRX icon

Millennium Management’s Pliant Therapeutics PLRX Stock Holding History

Millennium Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,500
Closed -$371K – 6453
2023
Q2 		$371K Buy
+20,500
New +$485K ﹤0.01% 4750

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Millennium Management's PLRX Position: Q1 2026 in Review

Millennium Management increased its Pliant Therapeutics (PLRX) stake by 189% in Q1 2026, buying an estimated $974K and bringing the position to 1,180,518 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Millennium Management first reported a position in PLRX in Q2 2020 and has held it in 21 quarters since. The position peaked at $9.89M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Millennium Management held 1,180,518 shares of Pliant Therapeutics worth $1.49M as of Q1 2026.
  • Millennium Management bought 771,687 Pliant Therapeutics shares in Q1 2026, an estimated $974K.
  • Pliant Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4114 holding.
  • Millennium Management first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Millennium Management's Pliant Therapeutics position peaked at $9.89M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.